secwatch.observer — SEC 8-K summary
======================================

Issuer:     THERALINK TECHNOLOGIES, INC. (—)
CIK:        0001362703
Form:       8-K
Filed at:   2023-06-29T23:59:59+00:00
Accession:  0001493152-23-022908
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Theralink appoints Faith Zaslavsky as CEO; Mick Ruxin becomes CMO
-----------------------------------------------------------------

- Faith Zaslavsky appointed CEO effective June 26, 2023; previously President and COO since December 2022.
- Former CEO Mick Ruxin transitions to Chief Medical Officer.
- Company is in process of merging with IMAC Holdings, Inc. (NASDAQ: BACK).
- Zaslavsky has over 23 years of genomics experience, including commercializing BRCA tests.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1362703/000149315223022908/0001493152-23-022908-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1362703/000149315223022908/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-022908

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer